BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 24792658)

  • 21. Nonsurgical management of high-risk lesions diagnosed at core needle biopsy: can malignancy be ruled out safely with breast MRI?
    Linda A; Zuiani C; Furlan A; Lorenzon M; Londero V; Girometti R; Bazzocchi M
    AJR Am J Roentgenol; 2012 Feb; 198(2):272-80. PubMed ID: 22268168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contrast-enhanced MR imaging of the breast at 3.0 and 1.5 T in the same patients: initial experience.
    Kuhl CK; Jost P; Morakkabati N; Zivanovic O; Schild HH; Gieseke J
    Radiology; 2006 Jun; 239(3):666-76. PubMed ID: 16549623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Breast MR imaging: computer-aided evaluation program for discriminating benign from malignant lesions.
    Williams TC; DeMartini WB; Partridge SC; Peacock S; Lehman CD
    Radiology; 2007 Jul; 244(1):94-103. PubMed ID: 17507720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Background parenchymal signal enhancement ratio at preoperative MR imaging: association with subsequent local recurrence in patients with ductal carcinoma in situ after breast conservation surgery.
    Kim SA; Cho N; Ryu EB; Seo M; Bae MS; Chang JM; Moon WK
    Radiology; 2014 Mar; 270(3):699-707. PubMed ID: 24126372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimization of time-to-peak analysis for differentiating malignant and benign breast lesions with dynamic contrast-enhanced MRI.
    Liu F; Kornecki A; Shmuilovich O; Gelman N
    Acad Radiol; 2011 Jun; 18(6):694-704. PubMed ID: 21420329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MR intervention: indications, technique, correlation and histologic.
    Philpotts LE
    Magn Reson Imaging Clin N Am; 2010 May; 18(2):323-32, x. PubMed ID: 20494315
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Second-look targeted studies after breast magnetic resonance imaging: practical tips to improve lesion identification.
    Trop I; Labelle M; David J; Mayrand MH; Lalonde L
    Curr Probl Diagn Radiol; 2010; 39(5):200-11. PubMed ID: 20674767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic performance of a dedicated 1.5-T breast MR imaging system.
    Hillman BJ; Harms SE; Stevens G; Stough RG; Hollingsworth AB; Kozlowski KF; Moss LJ
    Radiology; 2012 Oct; 265(1):51-8. PubMed ID: 22923716
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Magnetic resonance imaging of the breast for cancer diagnosis and staging.
    Monticciolo DL
    Semin Ultrasound CT MR; 2011 Aug; 32(4):319-30. PubMed ID: 21782122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Handling a high relaxivity contrast material for dynamic breast MR imaging using higher thresholds for the initial enhancement.
    Carbonaro LA; Verardi N; Di Leo G; Sardanelli F
    Invest Radiol; 2010 Mar; 45(3):114-20. PubMed ID: 20065856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current status of breast MR imaging. Part 2. Clinical applications.
    Kuhl CK
    Radiology; 2007 Sep; 244(3):672-91. PubMed ID: 17709824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differentiating benign from malignant enhancing lesions identified at MR imaging of the breast: are time-signal intensity curves an accurate predictor?
    Orel SG
    Radiology; 1999 Apr; 211(1):5-7. PubMed ID: 10189447
    [No Abstract]   [Full Text] [Related]  

  • 33. Can MR Imaging contribute in characterizing well-circumscribed breast carcinomas?
    Yoo JL; Woo OH; Kim YK; Cho KR; Yong HS; Seo BK; Kim A; Kang EY
    Radiographics; 2010 Oct; 30(6):1689-702. PubMed ID: 21071383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contrast media in breast imaging.
    Serrano LF; Morrell B; Mai A
    Magn Reson Imaging Clin N Am; 2012 Nov; 20(4):777-89. PubMed ID: 23088950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patient follow-up after concordant histologically benign imaging-guided biopsy of MRI-detected lesions.
    Sung JS; Lee CH; Morris EA; Comstock CE; Dershaw DD
    AJR Am J Roentgenol; 2012 Jun; 198(6):1464-9. PubMed ID: 22623564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The clinical significance of breast MRI in the management of ductal carcinoma in situ diagnosed on needle biopsy.
    Miyashita M; Amano G; Ishida T; Tamaki K; Uchimura F; Ono T; Yajima M; Kuriya Y; Ohuchi N
    Jpn J Clin Oncol; 2013 Jun; 43(6):654-63. PubMed ID: 23592884
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MR features to suggest microinvasive ductal carcinoma of the breast: can it be differentiated from pure DCIS?
    Hahn SY; Han BK; Ko EY; Shin JH; Hwang JY; Nam M
    Acta Radiol; 2013 Sep; 54(7):742-8. PubMed ID: 23588154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frequency of malignancy in lesions classified as probably benign after dynamic contrast-enhanced breast MRI examination.
    Sadowski EA; Kelcz F
    J Magn Reson Imaging; 2005 May; 21(5):556-64. PubMed ID: 15834907
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Indications for breast MRI: case-based review.
    Argus A; Mahoney MC
    AJR Am J Roentgenol; 2011 Mar; 196(3 Suppl):WS1-14. PubMed ID: 21343536
    [No Abstract]   [Full Text] [Related]  

  • 40. Magnetic resonance mammography in small vs. advanced breast lesions - systematic comparison reveals significant impact of lesion size on diagnostic accuracy in 936 histologically verified breast lesions.
    Dietzel M; Baltzer PA; Vag T; Gröschel T; Richter C; Burmeister H; Kaiser WA
    Rofo; 2011 Feb; 183(2):126-35. PubMed ID: 20830650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.